Partnering
Like the relationships SkyePharma wishes to build, our goals are long term. So, to forge lasting bonds of mutual interest, our aim is to support and improve your competitiveness. Our success is evident from our portfolio of partners, many who have come back with additional programmes.
With twelve drugs developed for our partners, we bring a wealth of knowledge and know how along with development and clinical capabilities to leverage our inhalation and oral drug delivery technologies to help make your drugs better.
Using our in-house computer modelling programs we can carry out in-silico feasibility assessments to determine if a proposed drug is a candidate for development with our technologies. We can then provide our partners with a full range of drug development services from formulation development to scale up, through clinical trials and regulatory submissions to full-scale manufacturing and packaging. Throughout this process, SkyePharma will work closely with our partners to provide the required drug delivery profile to an agreed time frame.
To achieve this, our capability, efficiency, and overall expertise are put at your disposal from the initial contact to ensure that the activities, deliverables and timelines are clear and agreed upon. With careful planning, we help you identify the quickest route to market. Dedicated project teams are formed to ensure up-to-date communication and efficient and smooth project progression which allow us to deliver quality and timely results.
Copyright 2008, SkyePharma. All Rights Reserved.
SkyePharma PLC is a public limited company registered in England and Wales, registration number 0107582.
Registered office: 105 Piccadilly, London, W1J 7NJ, United Kingdom

Business Development or Licensing Enquiries
E-mail your enquiry to: partnering@skyepharma.com
SkyePharma PLC
Tel: +44 207 491 1777
Fax: +44 207 491 3338
105 Piccadilly
London
W1J 7NJ
SkyePharma US, Inc
Tel: +1 857 891 0883
Fax: +1 617 401 3618
One Broadway
14th Floor
Cambridge
MA 02142
USA